Exchange Capital Management’s GSK GSK Stock Holding History

Exchange Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$1.29M	Buy	33,503 +23,619	+239%	+$903K	0.19%	114
2025 Q1	$383K	Buy	9,884 +748	+8%	+$27.4K	0.06%	172
2024 Q4	$309K	Buy	9,136 +1,515	+20%	+$54.5K	0.05%	189
2024 Q3	$312K	Buy	7,621 +367	+5%	+$15K	0.05%	174
2024 Q2	$279K	Buy	+7,254	New	+$305K	0.05%	178
2016 Q3	–	Sell	-124	Closed	-$7K	–	245
2016 Q2	$7K	Buy	+124	New	+$6.53K	﹤0.01%	190

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return

Exchange Capital Management's GSK Position: Q2 2025 in Review

Exchange Capital Management increased its GSK (GSK) stake by 239% in Q2 2025, buying an estimated $903K and bringing the position to 33,503 shares worth $1.29M. The position accounts for 0.19% of the portfolio, ranked #114.

Exchange Capital Management first reported a position in GSK in Q2 2016 and has held it in 6 quarters since. 891 funds tracked by Wall St. Rank hold GSK as of Q2 2025.

Exchange Capital Management held 33,503 shares of GSK worth $1.29M as of Q2 2025.
Exchange Capital Management bought 23,619 GSK shares in Q2 2025, an estimated $903K.
GSK made up 0.19% of Exchange Capital Management's portfolio in Q2 2025, its #114 holding.
Exchange Capital Management first reported a position in GSK in Q2 2016 and has held it in 6 quarters since.
891 funds tracked by Wall St. Rank held GSK as of Q2 2025.

Based on Exchange Capital Management's 13F filing for Q2 2025, filed 21 Jul 2025.